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Defects in microvascular perfusion, which is important for nutrient exchange in skeletal 
muscle, contribute to insulin resistance associated with obesity and hypertension. One 
factor that may link this microvascular dysfunction in these conditions is the renin 
angiotensin system (RAS). The primary objective of this thesis was to address these 
issues using rat models of obesity and altered RAS activity. 
Two different models of insulin resistance were analysed for the involvement of 
microvascular dysfunction. Rats were fed either a high fat or a high salt diet for 4 weeks 
to develop insulin resistance. The hyperinsulinaemic, euglycaemic clamp and 1-methyl 
xanthine techniques were used to investigate insulin sensitivity and microvascular 
recruitment, respectively. Despite different origins of insulin resistance, both animal 
models had markedly impaired insulin-mediated microvascular recruitment in muscle. 
The contribution of increased angiotensin II (AngII) activity to microvascular 
dysfunction in both animal models was examined. Hindleg vascular AngII sensitivity 
(assessed using both the perfused rat hindlimb technique and locally infused AngII in 
vivo) was enhanced in the high salt but not the high fat-fed rat. Thus, although both 
models developed microvascular insulin resistance, only the high salt-fed rats exhibited 
increased vascular AngII activity.  
There is conflicting evidence as to whether RAS dysregulation also contributes to insulin 
resistance or type 2 diabetes associated with obesity. The obese Zucker rat (a model of 
type 2 diabetes) has impaired insulin-mediated microvascular recruitment, and has been 
reported to have a dysregulated RAS, but represents a later stage of insulin resistance 
than the high fat-fed rat. To determine whether RAS inhibition enhances insulin 
sensitivity, high salt-fed and obese Zucker rats were treated with an angiotensin 
converting enzyme inhibitor (quinapril) for 4 weeks. Inhibition of ACE significantly 
improved insulin sensitivity and augmented insulin-stimulated microvascular perfusion 
in high salt-fed rats, but not in obese Zucker rats.  
The data from this thesis demonstrate that the origin of microvascular insulin resistance 
is multifactorial. Dysregulation of the RAS is important in some but not all forms of 
microvascular insulin resistance. Therefore inhibition of RAS may not always be 
effective at treating insulin resistance and may only be beneficial during earlier stages of 
insulin resistance rather than later stages such as type 2 diabetes. 
